Comparison of Post-Operative Pain Occurrence After Single Visit Root Canal Treatment
Launched by NATIONAL RESEARCH CENTRE, EGYPT · Jan 10, 2025
Trial Information
Current as of November 14, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This trial is comparing two different dental tool systems to see if they affect pain after a single-visit root canal treatment for a painful lower first molar (symptomatic irreversible pulpitis). In this randomized study, about 80 adults will be assigned by chance to use either the ProTaper Universal rotary system or the M-Pro rotary system during one dental visit. The main question is whether one system leads to less or milder postoperative pain. Pain will be recorded by the patient at 24 hours and again at 7 days after the procedure, using a 10-point scale (0 = no pain, 10 = worst pain). If needed, pain medicines will be provided.
To be eligible, adults 25–45 years old who are healthy, have a diagnosis of symptomatic irreversible pulpitis in a lower first molar, and meet a few safety criteria can participate. Exclusions include pregnancy, pain in more than one molar on the same side, teeth that react to tapping (percussion), recent use of painkillers within 12 hours, significant tooth mobility, or certain tooth or jaw conditions seen on X-rays. The study is being conducted in Cairo, Egypt, at the National Research Centre, and is currently enrolling by invitation. Results are not yet available.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient's diagnosis is symptomatic irreversible pulpitis in mandibular first molar.
- • Males and females patients in a good health.
- • Aged from 25 to 45 years old.
- • Pulp vitality is confirmed with cold pulp test and an electric pulp test.
- Exclusion Criteria:
- • Pregnant females.
- • Patients complaining from pain in more than one molar on the same side.
- • Patients whose teeth react positively to percussion test.
- • Patients who receive analgesics 12 hours before the start of the root canal treatment.
- • Teeth having grade 2 or 3 mobility.
- • Presence of periapical radiolucency or teeth with extra oral or intraoral sinus tract or fistula.
About National Research Centre, Egypt
The National Research Centre (NRC) in Egypt is a leading institution dedicated to advancing scientific research and innovation across various disciplines, including health and medicine. Established to support national development, the NRC conducts cutting-edge clinical trials aimed at improving public health outcomes and addressing pressing medical challenges. With a commitment to ethical research practices and collaboration with local and international partners, the NRC plays a pivotal role in fostering advancements in medical science, contributing to evidence-based healthcare solutions, and enhancing the quality of life for communities in Egypt and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported